Resected pancreatic cancer outcomes in the elderly

Journal of Geriatric Oncology

Volumn 6, Issue 2, 2015, Pages 127-132

  Frakes, Jessica M ^a   Strom, Tobin ^a   Springett, Gregory M ^a   Hoffe, Sarah E ^a   Balducci, Lodovico ^a   Hodul, Pamela ^a   Malafa, Mokenge P ^a   Shridhar, Ravi ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Adjuvant therapy; Age; Elderly; Pancreatic cancer; Surgery

Indexed keywords

CA 19-9 ANTIGEN;

ABSCESS; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTROJEJUNOSTOMY LEAK; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS RESECTION; PANCREATIC LEAK; PERITONITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL INFECTION; SURVIVAL RATE; SURVIVAL TIME; WOUND DEHISCENCE; ADJUVANT CHEMORADIOTHERAPY; CARCINOMA; COHORT ANALYSIS; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; UTILIZATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84925141557     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2014.11.005     Document Type: Article

References (17)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64(1):9-29.
2. SEER cancer statistics review 2008, 1975-2005. [Available at: http://seer.cancer.gov/csr/1975-2005/. Based on November 2007 SEER data submission, posted to the SEER Web site]. L.K.M. Ries, D.G. Stinchcomb, D. Melbert, M. Krapcho, N. Howlader, M.J. Horner (Eds.).
3. Brozzetti S., Mazzoni G., Miccini M., Puma F., De Angelis M., Cassini D., et al. Surgical treatment of pancreatic head carcinoma in elderly patients. Arch Surg 2006, 141(2):137-142.
4. Makary M.A., Winter J.M., Cameron J.L., Campbell K.A., Chang D., Cunningham S.C., et al. Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg 2006, 10(3):347-356.
5. Brennan M.F., Kattan M.W., Klimstra D., Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004, 240(2):293-298.
6. Sohn T.A., Yeo C.J., Cameron J.L., Lillemoe K.D., Talamini M.A., Hruban R.H., et al. Should pancreaticoduodenectomy be performed in octogenarians?. J Gastrointest Surg 1998, 2(3):207-216.
7. Kalser M.H., Ellenberg S.S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985, 120(8):899-903.
8. Herman J.M., Swartz M.J., Hsu C.C., Winter J., Pawlik T.M., Sugar E., et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008, 26(21):3503-3510.
9. Corsini M.M., Miller R.C., Haddock M.G., Donohue J.H., Farnell M.B., Nagorney D.M., et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 2008, 26(21):3511-3516.
10. Neoptolemos J.P., Dunn J.A., Stocken D.D., Almond J., Link K., Beger H., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001, 358(9293):1576-1585.
11. Neoptolemos J.P., Stocken D.D., Friess H., Bassi C., Dunn J.A., Hickey H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004, 350(12):1200-1210.
12. Van Laethem J.L., Hammel P., Mornex F., Azria D., Van Tienhoven G., Vergauwe P., et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. J Clin Oncol 2010, 28(29):4450-4456.
13. Horowitz D.P., Hsu C.C., Wang J., Makary M.A., Winter J.M., Robinson R., et al. Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2011, 80(5):1391-1397.
14. Miyamoto D.T., Mamon H.J., Ryan D.P., Willett C.G., Ancukiewicz M., Kobayashi W.K., et al. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75years or older. Int J Radiat Oncol Biol Phys 2010, 77(4):1171-1177.
15. Turrini O., Paye F., Bachellier P., Sauvanet A., Sa Cunha A., Le Treut Y.P., et al. Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association. Eur J Surg Oncol 2013, 39(2):171-178.
16. Lee D.Y., Schwartz J.A., Wexelman B., Kirchoff D., Yang K.C., Attiyeh F. Outcomes of pancreaticoduodenectomy for pancreatic malignancy in octogenarians: an American College of Surgeons National Surgical Quality Improvement Program analysis. Am J Surg 2014, 207(4):540-548.
17. Adham M., Bredt L.C., Robert M., Perinel J., Lombard-Bohas C., Ponchon T., et al. Pancreatic resection in elderly patients: should it be denied?. Langenbecks Arch Surg 2014, 399(4):449-459.